Elizabeth Nally, Medical Oncology SpR at Barts Health, shared Sumanta K. Pal’s, Vice Chair of Academic Affairs and Professor at City of Hope, post on X, adding:
“Thank you Sumanta K. Pal, really appreciate the support and kind words. It was a privilege to present these analyses from IMmotion010, none of this work would have been possible without your leadership on the trial.”
Quoting Sumanta K. Pal’s post:
“The best talk I have heard in a long time addressing HRQOL in cancer.
With mentorship from Tom Powles, Barts Experimental Cancer Medicine Centre, Elizabeth Nally presents a pragmatic and meaningful reclassification of toxicity as ‘life-changing’ vs ‘sig long term’ vs ‘sig short term’ vs ‘non-significant’ – definitions arrived at with counsel and with patients.
From IMmotion010, some phenomenal insights on how this framework could reclassify CTCAE G1-4 toxicity, a long held frustration in defining the patient experience. Well done! ”
Other articles featuring Elizabeth Nally and Sumanta K. Pal on OncoDaily.
